Latest1 information on COVID-19
©2022 Stanford Medicine
Thromboelastography to Assess Hemostatic Changes in Patients Undergoing Elective Cesarean Delivery.
Not Recruiting
Trial ID: NCT00767832
Purpose
The purpose of the study is to assess the coagulation changes that occur in patients
undergoing elective Cesarean delivery using thromboelastography (TEG). We will compare
coagulation data to assess potential coagulation changes associated with hemoglobin changes
before and after surgery, and related to estimated blood loss.
Official Title
Thromboelastography to Assess Hemostatic Changes in Patients Undergoing Elective Cesarean Delivery.
Stanford Investigator(s)
Alex Butwick
Professor of Anesthesiology, Perioperative and Pain Medicine (OB)
Lindsey Ralls
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
Eligibility
Inclusion Criteria:
- All obstetric patients with singleton pregnancies admitted to the labor and delivery
unit at Lucile Packard Hospital who undergo elective Cesarean delivery.
- We will select 100 healthy ASA 1 patients with singleton pregnancies who are scheduled
for uncomplicated elective Cesarean delivery, with no anticipated risk of obstetric
hemorrhage.
Exclusion Criteria:
- Patients with underlying coagulation disorders.
- Patients with thrombocytopenia.
- Patients with pregnancy-induced hypertension, pre-eclampsia.
- Patients requiring the following medications prior to surgery: NSAIDS, aspirin,
anticoagulants.
- Patients requiring non-elective Cesarean delivery.
- Patients with significant obstetric or medical disease.
- No patients <18 years of age will be recruited.
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Alexander Butwick